首页 > 最新文献

Bifidobacteria and Microflora最新文献

英文 中文
Effective Dose of Lactosucrose on Fecal Flora and Fecal Metabolites of Humans 乳糖对人体粪便菌群和粪便代谢产物的有效剂量
Pub Date : 1900-01-01 DOI: 10.12938/BIFIDUS1982.13.2_8
H. Hara, Shou-Tou Li, Masakuni Sasaki, T. Maruyama, A. Terada, Y. Ogata, K. Fujita, H. Ishigami, K. Hara, I. Fujimori, T. Mitsuoka
Lactosucrose (4G-B-D-galactosylsucrose) was fermented in vitro by bifidobacteria and lactobacilli, and to a limited degree by the Bacteroides fragilis group, clostridia, eubacteria, and enterobacteriaceae. The effects of dietary lactosucrose on the fecal flora and fecal metabolites were studied in eight healthy volunteers (20-23 years of age) who ingested 3 g of lactosucrose/day for 7 days followed by 6 g of lactosucrose/day for 7 consecutive days. During lactosucrose intake, the counts of bifidobacteria were increased significantly (p< 0.001), whereas the counts of clostridia, including Clostridium perfringens, and bacteroidaceae were decreased significantly (p<0.05) compared with the values before the intake. The total bacterial counts were decreased significantly (p< 0.05) on day 14 during the intake. The frequency of occurrence of lecithinase-negative clostridia was decreased significantly (p<0.05) when compared with the values before and after the intake. No detectable changes occurred in the counts of other organisms throughout the experimental periods. Fecal concentrations of ammonia, sulfide, phenol, ethylphenol, skatol and indole were decreased significantly (p< 0.05) during lactosucrose intake. Acetic acid and lactic acid were increased significantly (p< 0.05) during the intake. Fecal enzyme activity of B-glucuronidase was decreased significantly (p< 0.05) on day 14 of the intake. Serum very low density lipoprotein (VLDL) was increased significantly (p< 0.01) on day 14 during the intake. Mean fecal pH values decreased from 6.3 to 5.9, and mean water content increased 3.6% during the intake. Fecal weight was increased slightly during the intake. The results obtained showed that the effective dose of lactosucrose for all healthy adults is 3 g/day.
乳糖(4g - b - d -半乳糖糖)由双歧杆菌和乳酸菌体外发酵,脆弱拟杆菌群、梭状芽胞杆菌、真细菌和肠杆菌科也有一定程度的体外发酵。在8名健康志愿者(20-23岁)中,研究了膳食蔗糖对粪便菌群和粪便代谢物的影响,他们连续7天每天摄入3g蔗糖,然后连续7天每天摄入6g蔗糖。饲喂乳糖期间,与饲喂前相比,双歧杆菌数量显著增加(p< 0.001),包括产气荚膜梭菌在内的梭菌数量和拟杆菌科数量显著减少(p<0.05)。饲粮第14天细菌总数显著降低(p< 0.05)。与摄入前后相比,卵磷脂酶阴性梭菌的出现频率显著降低(p<0.05)。在整个实验期间,其他生物的计数没有发生可检测到的变化。饲喂乳糖后,粪便中氨、硫化物、苯酚、乙酚、甲胺醇和吲哚的浓度显著降低(p< 0.05)。采食期间乙酸和乳酸显著升高(p< 0.05)。饲粮第14天粪便中b -葡萄糖醛酸酶活性显著降低(p< 0.05)。饲粮第14天血清极低密度脂蛋白(VLDL)极显著升高(p< 0.01)。平均粪便pH值从6.3降至5.9,平均含水量增加3.6%。进食期间粪便重量略有增加。结果表明,所有健康成人的有效剂量为3 g/d。
{"title":"Effective Dose of Lactosucrose on Fecal Flora and Fecal Metabolites of Humans","authors":"H. Hara, Shou-Tou Li, Masakuni Sasaki, T. Maruyama, A. Terada, Y. Ogata, K. Fujita, H. Ishigami, K. Hara, I. Fujimori, T. Mitsuoka","doi":"10.12938/BIFIDUS1982.13.2_8","DOIUrl":"https://doi.org/10.12938/BIFIDUS1982.13.2_8","url":null,"abstract":"Lactosucrose (4G-B-D-galactosylsucrose) was fermented in vitro by bifidobacteria and lactobacilli, and to a limited degree by the Bacteroides fragilis group, clostridia, eubacteria, and enterobacteriaceae. The effects of dietary lactosucrose on the fecal flora and fecal metabolites were studied in eight healthy volunteers (20-23 years of age) who ingested 3 g of lactosucrose/day for 7 days followed by 6 g of lactosucrose/day for 7 consecutive days. During lactosucrose intake, the counts of bifidobacteria were increased significantly (p< 0.001), whereas the counts of clostridia, including Clostridium perfringens, and bacteroidaceae were decreased significantly (p<0.05) compared with the values before the intake. The total bacterial counts were decreased significantly (p< 0.05) on day 14 during the intake. The frequency of occurrence of lecithinase-negative clostridia was decreased significantly (p<0.05) when compared with the values before and after the intake. No detectable changes occurred in the counts of other organisms throughout the experimental periods. Fecal concentrations of ammonia, sulfide, phenol, ethylphenol, skatol and indole were decreased significantly (p< 0.05) during lactosucrose intake. Acetic acid and lactic acid were increased significantly (p< 0.05) during the intake. Fecal enzyme activity of B-glucuronidase was decreased significantly (p< 0.05) on day 14 of the intake. Serum very low density lipoprotein (VLDL) was increased significantly (p< 0.01) on day 14 during the intake. Mean fecal pH values decreased from 6.3 to 5.9, and mean water content increased 3.6% during the intake. Fecal weight was increased slightly during the intake. The results obtained showed that the effective dose of lactosucrose for all healthy adults is 3 g/day.","PeriodicalId":414713,"journal":{"name":"Bifidobacteria and Microflora","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114811557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 72
Comparison of Antimicrobial Susceptibility of the Bacteroides vulgatus and B. fragilis Strains Isolated from Feces or Bowel Tissue Specimens of Patients with Ulcerative Colitis and Those from Feces of Healthy Adults 溃疡性结肠炎患者粪便或肠组织标本与健康成人粪便中普通拟杆菌和脆弱芽孢杆菌的药敏比较
Pub Date : 1900-01-01 DOI: 10.12938/BIFIDUS1982.10.2_131
T. Chida, N. Okamura, R. Nakaya, Y. Benno, T. Mitsuoka
The in vitro activity of selected antibiotics were determined for the strains of Bacteroides vulgatus and B. fragilis isolated from the feces and bowel tissue specimens of patients with ulcerative colitis (UC) and from the feces of healthy adults by an agar dilution method. Significant differences in resistance rates to ampicillin, tetracycline, and macrolide-lincosamide were observed between the strains of B. vulgatus, but not B. fragilis, isolated from the patients with UC and those from the healthy adults.
采用琼脂稀释法对溃疡性结肠炎(UC)患者粪便和肠组织标本以及健康成人粪便中分离的普通拟杆菌(Bacteroides vulgatus)和脆弱芽孢杆菌(B.脆性芽孢杆菌)进行体外活性测定。从UC患者中分离的普通芽孢杆菌与健康成人分离的脆弱芽孢杆菌对氨苄西林、四环素和大环内酯- lincoamide的耐药率存在显著差异,但未见明显差异。
{"title":"Comparison of Antimicrobial Susceptibility of the Bacteroides vulgatus and B. fragilis Strains Isolated from Feces or Bowel Tissue Specimens of Patients with Ulcerative Colitis and Those from Feces of Healthy Adults","authors":"T. Chida, N. Okamura, R. Nakaya, Y. Benno, T. Mitsuoka","doi":"10.12938/BIFIDUS1982.10.2_131","DOIUrl":"https://doi.org/10.12938/BIFIDUS1982.10.2_131","url":null,"abstract":"The in vitro activity of selected antibiotics were determined for the strains of Bacteroides vulgatus and B. fragilis isolated from the feces and bowel tissue specimens of patients with ulcerative colitis (UC) and from the feces of healthy adults by an agar dilution method. Significant differences in resistance rates to ampicillin, tetracycline, and macrolide-lincosamide were observed between the strains of B. vulgatus, but not B. fragilis, isolated from the patients with UC and those from the healthy adults.","PeriodicalId":414713,"journal":{"name":"Bifidobacteria and Microflora","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114174415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Biofermin-R Administered in Combination with Antibiotics on the Fecal Flora 生物发酵素- r与抗生素联用对粪便菌群的影响
Pub Date : 1900-01-01 DOI: 10.12938/BIFIDUS1982.4.1_23
M. Yamashita, M. Hatano, Hajime Nakamura, R. Murakami, M. Matsuo, T. Matsuo, Yasushi Kumon
For the purpose of investigating the effects of Biofermin-R (BF-R) on the bacterial flora, BF-R was administered in combination with antibiotics , and the fecal flora of children treated with antibiotics alone was compared with that of children treated with both BF-R and antibiotics. Three types of effects were investigated: 1) the inhibitory effect on antibiotic-induced changes of the bacterial flora in patients without diarrhea , 2) the bacterial flora-maintaining and normalizing effect in patients with gastrointestinal symptoms, and 3) the process of normalizing in the fecal bacterial flora of mice administered with antibiotics. The results indicated that the concurrent use of BF-R and an antibiotic inhibited the changes of the intestinal flora that usually occur during antibiotic therapy alone, by preventing a decrease in Bifidobacterium, and restored disturbed flora to normal.
为了研究生物铁蛋白- r (BF-R)对细菌菌群的影响,我们将BF-R与抗生素联合使用,并比较单独使用抗生素的儿童与同时使用BF-R和抗生素的儿童的粪便菌群。研究了三种作用:1)抗生素对非腹泻患者细菌菌群变化的抑制作用;2)胃肠道症状患者细菌菌群维持和正常化作用;3)抗生素给药小鼠粪便细菌菌群的正常化过程。结果表明,BF-R与抗生素同时使用,通过防止双歧杆菌的减少,抑制了抗生素单独治疗时肠道菌群的变化,使受干扰的菌群恢复正常。
{"title":"Effects of Biofermin-R Administered in Combination with Antibiotics on the Fecal Flora","authors":"M. Yamashita, M. Hatano, Hajime Nakamura, R. Murakami, M. Matsuo, T. Matsuo, Yasushi Kumon","doi":"10.12938/BIFIDUS1982.4.1_23","DOIUrl":"https://doi.org/10.12938/BIFIDUS1982.4.1_23","url":null,"abstract":"For the purpose of investigating the effects of Biofermin-R (BF-R) on the bacterial flora, BF-R was administered in combination with antibiotics , and the fecal flora of children treated with antibiotics alone was compared with that of children treated with both BF-R and antibiotics. Three types of effects were investigated: 1) the inhibitory effect on antibiotic-induced changes of the bacterial flora in patients without diarrhea , 2) the bacterial flora-maintaining and normalizing effect in patients with gastrointestinal symptoms, and 3) the process of normalizing in the fecal bacterial flora of mice administered with antibiotics. The results indicated that the concurrent use of BF-R and an antibiotic inhibited the changes of the intestinal flora that usually occur during antibiotic therapy alone, by preventing a decrease in Bifidobacterium, and restored disturbed flora to normal.","PeriodicalId":414713,"journal":{"name":"Bifidobacteria and Microflora","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131263807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Current Status and Future Trends of Bifidobacteria-related Research and Products in the USA 美国双歧杆菌相关研究和产品的现状和未来趋势
Pub Date : 1900-01-01 DOI: 10.12938/BIFIDUS1982.10.2_113
D. Hoover, D. B. Hughes
Bifidobacteria have been known and studied throughout the 20th century. The early work originated at the Pasteur Institute. Since that time basic and applied research on bifidobacteria have been done worldwide, with a portion carried out in the U.S. Presently Japan dominates the study and development of bifidobacteria for human use. This article examines some of the possible reasons for the minor role of the U.S. in the study of bifidobacteria and development of bifidobacteria-amended products, with a discussion of future trends in this area.
双歧杆菌在整个20世纪都被认识和研究。早期的工作起源于巴斯德研究所。从那时起,双歧杆菌的基础研究和应用研究在世界范围内开展,其中一部分在美国开展。目前,日本在双歧杆菌的人类应用研究和开发方面处于主导地位。本文探讨了美国在双歧杆菌研究和双歧杆菌改性产品开发中的次要作用的一些可能原因,并讨论了该领域的未来趋势。
{"title":"Current Status and Future Trends of Bifidobacteria-related Research and Products in the USA","authors":"D. Hoover, D. B. Hughes","doi":"10.12938/BIFIDUS1982.10.2_113","DOIUrl":"https://doi.org/10.12938/BIFIDUS1982.10.2_113","url":null,"abstract":"Bifidobacteria have been known and studied throughout the 20th century. The early work originated at the Pasteur Institute. Since that time basic and applied research on bifidobacteria have been done worldwide, with a portion carried out in the U.S. Presently Japan dominates the study and development of bifidobacteria for human use. This article examines some of the possible reasons for the minor role of the U.S. in the study of bifidobacteria and development of bifidobacteria-amended products, with a discussion of future trends in this area.","PeriodicalId":414713,"journal":{"name":"Bifidobacteria and Microflora","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129059032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Effects of Administration of TOS and Bifidobacterium breve 4006 on the Human Fecal Flora 注射TOS和短双歧杆菌4006对人类粪便菌群的影响
Pub Date : 1900-01-01 DOI: 10.12938/BIFIDUS1982.2.1_17
R. Tanaka, H. Takayama, M. Morotomi, T. Kuroshima, S. Ueyama, Keisuke Matsumoto, A. Kuroda, M. Mutai
We studied the effects of administration of TOS, a new growth factor derived from lactose for Bifidobacterium, and Bifidobacterium breve 4006 on the fecal flora of normal subjects. All of the Bifidobacterium species tested, eight reference strains and B. breve 4006 were capable of fermenting TOS in vitro, while others, 2 Bacteroides strains and 4 Lactobacillus and Enterobacteriaceae strains, showed an appreciable growth among 55 cultures tested. It was evident that TOS is not intestinally absorbed by the recipient subjects, from hydrogen breath test. In vivo, TOS (3g or 10g/day) was observed to promote the growth of both administered B. breve 4006 and resident Bifidobacterium strains. Simultaneous administration of B. breve 4006 and TOS caused the suppression of gram negative anaerobes and aerobes, Bacteroidaceae nd Enterobacteriaceae , and the reduction of fecal ammonia and urinary indican excretion. It is concluded that TOS is a typical bifidus factor.
我们研究了给药双歧杆菌(一种从乳糖中提取的新的生长因子)和短双歧杆菌4006对正常受试者粪便菌群的影响。所有的双歧杆菌、8株参考菌株和短杆菌4006都能在体外发酵TOS,而其他菌株,2株拟杆菌和4株乳杆菌和肠杆菌科菌株在55株培养物中表现出明显的生长。从氢呼吸试验中可以看出,TOS没有被受体肠道吸收。在体内,观察到TOS (3g或10g/天)促进了给药短芽孢杆菌4006和常驻双歧杆菌菌株的生长。同时给药短芽孢杆菌4006和TOS可抑制革兰氏阴性厌氧菌和需氧菌、拟杆菌科和肠杆菌科,减少粪氨和尿指标排泄。结论:TOS是典型的双歧因素。
{"title":"Effects of Administration of TOS and Bifidobacterium breve 4006 on the Human Fecal Flora","authors":"R. Tanaka, H. Takayama, M. Morotomi, T. Kuroshima, S. Ueyama, Keisuke Matsumoto, A. Kuroda, M. Mutai","doi":"10.12938/BIFIDUS1982.2.1_17","DOIUrl":"https://doi.org/10.12938/BIFIDUS1982.2.1_17","url":null,"abstract":"We studied the effects of administration of TOS, a new growth factor derived from lactose for Bifidobacterium, and Bifidobacterium breve 4006 on the fecal flora of normal subjects. All of the Bifidobacterium species tested, eight reference strains and B. breve 4006 were capable of fermenting TOS in vitro, while others, 2 Bacteroides strains and 4 Lactobacillus and Enterobacteriaceae strains, showed an appreciable growth among 55 cultures tested. It was evident that TOS is not intestinally absorbed by the recipient subjects, from hydrogen breath test. In vivo, TOS (3g or 10g/day) was observed to promote the growth of both administered B. breve 4006 and resident Bifidobacterium strains. Simultaneous administration of B. breve 4006 and TOS caused the suppression of gram negative anaerobes and aerobes, Bacteroidaceae nd Enterobacteriaceae , and the reduction of fecal ammonia and urinary indican excretion. It is concluded that TOS is a typical bifidus factor.","PeriodicalId":414713,"journal":{"name":"Bifidobacteria and Microflora","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114720190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 242
Pathogenic Mechanisms of Bacterial Enteropathogens 细菌性肠病原体的致病机制
Pub Date : 1900-01-01 DOI: 10.12938/BIFIDUS1982.7.1_19
T. Miwatani, M. Kohda, T. Honda
Two important steps are involved in the pathogenesis of bacterial enteric pathogens. All the enteric pathogens, which enter the gastrointestinal tract through the mouth with food or water, colonize a certain part of the intestine. This important step is called colonization (4, 9) . For example, Vibrio cholerae and Vibrio parahaemolyticus colonize the mucosa of the upper jejunum, whereas Shigella colonizes the ileocaecum and colon. This event (colonization) is mediated by the production of specific surface antigens called "colonization factors" and specific receptors for the factors. The reason for the differences between the symptoms produced by V. cholerae O1 and V. parahaemolyticus, both of which colonize a similar region of the small intestine, is that they produce different toxins. Thus the second important step in the pathogenesis of bacterial enteric pathogens is the production of toxins and/or invasion.
肠道细菌病原体的发病机制涉及两个重要步骤。所有的肠道病原体,通过食物或水进入胃肠道,在肠道的某一部分定植。这个重要的步骤被称为殖民化(4,9)。例如,霍乱弧菌和副溶血性弧菌定植于空肠上部粘膜,而志贺氏菌定植于回肠盲肠和结肠。这一事件(定植)是由称为“定植因子”的特异性表面抗原和这些因子的特异性受体的产生介导的。O1型霍乱弧菌和副溶血性弧菌的症状不同的原因是它们产生不同的毒素,这两种弧菌都寄生在小肠的相似区域。因此,肠道细菌病原体发病机制的第二个重要步骤是毒素的产生和/或入侵。
{"title":"Pathogenic Mechanisms of Bacterial Enteropathogens","authors":"T. Miwatani, M. Kohda, T. Honda","doi":"10.12938/BIFIDUS1982.7.1_19","DOIUrl":"https://doi.org/10.12938/BIFIDUS1982.7.1_19","url":null,"abstract":"Two important steps are involved in the pathogenesis of bacterial enteric pathogens. All the enteric pathogens, which enter the gastrointestinal tract through the mouth with food or water, colonize a certain part of the intestine. This important step is called colonization (4, 9) . For example, Vibrio cholerae and Vibrio parahaemolyticus colonize the mucosa of the upper jejunum, whereas Shigella colonizes the ileocaecum and colon. This event (colonization) is mediated by the production of specific surface antigens called \"colonization factors\" and specific receptors for the factors. The reason for the differences between the symptoms produced by V. cholerae O1 and V. parahaemolyticus, both of which colonize a similar region of the small intestine, is that they produce different toxins. Thus the second important step in the pathogenesis of bacterial enteric pathogens is the production of toxins and/or invasion.","PeriodicalId":414713,"journal":{"name":"Bifidobacteria and Microflora","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129332709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Raffinose Intake on Human Fecal Microflora 棉子糖摄取量对人体粪便菌群的影响
Pub Date : 1900-01-01 DOI: 10.12938/BIFIDUS1982.6.2_59
Y. Benno, K. Endo, N. Shiragami, K. Sayama, Tomotari Mitsuokai
The effects of four-week raffinose intake (15 g/day) on the fecal microflora and fecal properties were studied in healthy human volunteers. The significantly increasing numbers of Bifidobacterium spp. were observed during the raffinose intake, whereas the numbers of lecithinase-negative Clostridium spp. and bacteroidaceae during the intake were significantly lower than those before and after the intake. The percentage of Bifidobacterium spp. was increased from 11.6-15.5% of the total to 58.2-80.1% of the total during the intake. The fecal pH values during the feeding were lower than those before and after the intake.
在健康人类志愿者中研究了4周棉子糖摄入(15 g/天)对粪便微生物群和粪便特性的影响。棉子糖饲喂期间双歧杆菌数量显著增加,卵磷脂酶阴性梭菌和拟杆菌数量显著低于饲喂前后。双歧杆菌在饲粮中所占比例由11.6 ~ 15.5%提高到58.2 ~ 80.1%。摄食期间粪便pH值均低于摄食前后。
{"title":"Effects of Raffinose Intake on Human Fecal Microflora","authors":"Y. Benno, K. Endo, N. Shiragami, K. Sayama, Tomotari Mitsuokai","doi":"10.12938/BIFIDUS1982.6.2_59","DOIUrl":"https://doi.org/10.12938/BIFIDUS1982.6.2_59","url":null,"abstract":"The effects of four-week raffinose intake (15 g/day) on the fecal microflora and fecal properties were studied in healthy human volunteers. The significantly increasing numbers of Bifidobacterium spp. were observed during the raffinose intake, whereas the numbers of lecithinase-negative Clostridium spp. and bacteroidaceae during the intake were significantly lower than those before and after the intake. The percentage of Bifidobacterium spp. was increased from 11.6-15.5% of the total to 58.2-80.1% of the total during the intake. The fecal pH values during the feeding were lower than those before and after the intake.","PeriodicalId":414713,"journal":{"name":"Bifidobacteria and Microflora","volume":"65 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134139018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 104
Bifidobacterium Species Expressing Phenotypical Similarity to Bifidobacterium adolescentis Isolated from the Feces of Human Adults 从成人粪便中分离的双歧杆菌与青春期双歧杆菌表型相似
Pub Date : 1900-01-01 DOI: 10.12938/BIFIDUS1982.11.1_25
T. Yaeshima, T. Fujisawa, T. Mitsuoka
Seventy-six strains of Bifidobacterium adolescentis and phenotypically similar Bifidobacterium species, of which 56 strains were isolated from the feces of human adults in our laboratory and 20 strains were obtained from DSM and ATCC as type strains or reference strains, were studied by carbohydrate fermentation patterns, DNA base compositions and DNA/DNA homologies. On the basis of DNA/DNA homology they were divided into six species: B. adolescentis, B. pseudocatenulatum, B. catenulatum, B. angulatum, B. dentium and B. longum. The strains of B. angulatum and B. dentium were not detected in 56 strains isolated from the feces of human adults. B. catenulatum could be distinguished from other four species, except for B. longum, by the inability to ferment glycogen and mannose. The G+C contents of DNAs of B. pseudocatenulatum and B. catenulatum (57.1•}0.7 mol% and 56.5•}1.0 mol%, respectively) were lower than that of B. adolescentis (59.8•}0.9 mol%). It was difficult to differentiate B. adolescentis biovar b and B. dentium, and B. adolescentis biovar c and B. pseudocatenulatum on the basis of carbohydrate fermentation pattern.
对76株青少年双歧杆菌和表型相似的双歧杆菌进行了碳水化合物发酵模式、DNA碱基组成和DNA/DNA同源性的研究,其中56株从实验室成人粪便中分离得到,20株从DSM和ATCC中获得作为类型菌株或参考菌株。根据DNA/DNA同源性将其划分为6个种:青春期白刺、假链纹白刺、链纹白刺、角纹白刺、牙纹白刺和长纹白刺。从成人粪便中分离的56株细菌未检出角状芽孢杆菌和牙状芽孢杆菌。除长叶镰刀菌外,长叶镰刀菌与其他四种镰刀菌的区别在于不能发酵糖原和甘露糖。伪长尾白刺和长尾白刺的G+C含量分别为57.1•0.7 mol%和56.5•1.0 mol%,低于青春期白刺的59.8•0.9 mol%。根据碳水化合物发酵模式,很难区分白僵菌b和牙僵菌、白僵菌c和伪绿僵菌。
{"title":"Bifidobacterium Species Expressing Phenotypical Similarity to Bifidobacterium adolescentis Isolated from the Feces of Human Adults","authors":"T. Yaeshima, T. Fujisawa, T. Mitsuoka","doi":"10.12938/BIFIDUS1982.11.1_25","DOIUrl":"https://doi.org/10.12938/BIFIDUS1982.11.1_25","url":null,"abstract":"Seventy-six strains of Bifidobacterium adolescentis and phenotypically similar Bifidobacterium species, of which 56 strains were isolated from the feces of human adults in our laboratory and 20 strains were obtained from DSM and ATCC as type strains or reference strains, were studied by carbohydrate fermentation patterns, DNA base compositions and DNA/DNA homologies. On the basis of DNA/DNA homology they were divided into six species: B. adolescentis, B. pseudocatenulatum, B. catenulatum, B. angulatum, B. dentium and B. longum. The strains of B. angulatum and B. dentium were not detected in 56 strains isolated from the feces of human adults. B. catenulatum could be distinguished from other four species, except for B. longum, by the inability to ferment glycogen and mannose. The G+C contents of DNAs of B. pseudocatenulatum and B. catenulatum (57.1•}0.7 mol% and 56.5•}1.0 mol%, respectively) were lower than that of B. adolescentis (59.8•}0.9 mol%). It was difficult to differentiate B. adolescentis biovar b and B. dentium, and B. adolescentis biovar c and B. pseudocatenulatum on the basis of carbohydrate fermentation pattern.","PeriodicalId":414713,"journal":{"name":"Bifidobacteria and Microflora","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129653598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
Phenotypic Characteristics in Distinguishing Clostridium butyricum from Clostridium beijerinckii 区分丁酸梭菌与贝氏梭菌的表型特征
Pub Date : 1900-01-01 DOI: 10.12938/BIFIDUS1982.7.1_56
T. Ikeda, Y. Benno, T. Fujisawa, T. Mitsuoka
{"title":"Phenotypic Characteristics in Distinguishing Clostridium butyricum from Clostridium beijerinckii","authors":"T. Ikeda, Y. Benno, T. Fujisawa, T. Mitsuoka","doi":"10.12938/BIFIDUS1982.7.1_56","DOIUrl":"https://doi.org/10.12938/BIFIDUS1982.7.1_56","url":null,"abstract":"","PeriodicalId":414713,"journal":{"name":"Bifidobacteria and Microflora","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114275645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Changes in Intestinal Condition, Fecal Microflora and Composition of Rectal Gas after Administration of Fructooligosaccharide and Lactulose at Different Doses 低聚果糖和乳果糖不同剂量对肠道状况、粪便菌群和直肠气体组成的影响
Pub Date : 1900-01-01 DOI: 10.12938/BIFIDUS1982.12.2_57
M. Kawaguchi, Y. Tashiro, T. Adachi, Z. Tamura
Our subject T, who appeared to be a suitable candidate for an assessment of the effects of oligosaccharides, was administrated fructooligosaccharide (FOS) or lactulose and his symptoms, fecal microflora, and composition of rectal gas were investigated. The subject experienced no symptoms in the gut at low dose of FOS. At high dose of FOS, tympanites was observed in the ascending and the transverse colon. By lactulose administration, there were no tympanites, but frequent defecation, rectal gas and loose stool were noted. The number and occupation percentage of fecal bifidobacteria increased by higher doses of FOS (109.1 to 1010.8, 2.9 to 66.2%) and lactulose (108.7 to 1010.5, 0.5 to 25.2%). The composition of rectal gas varied even among samples collected in succession and no clear relationship was observed between the composition of gas and dose. Based on these results, the course of tympanites is discussed.
我们的受试者T似乎是评估低聚糖作用的合适人选,他被给予低聚果糖(FOS)或乳果糖,并研究了他的症状、粪便微生物群和直肠气体的组成。受试者在低剂量FOS下没有出现肠道症状。高剂量FOS时,在升结肠和横结肠可见鼓室。经乳果糖治疗后,患者无鼓室现象,但排便频繁、直肠胀气、便稀。高剂量FOS(109.1 ~ 1010.8, 2.9 ~ 66.2%)和乳果糖(108.7 ~ 1010.5,0.5 ~ 25.2%)使粪便中双歧杆菌的数量和占比增加。直肠气体的组成即使在连续收集的样品中也有所不同,并且气体组成与剂量之间没有明显的关系。在此基础上,讨论了鼓泡的过程。
{"title":"Changes in Intestinal Condition, Fecal Microflora and Composition of Rectal Gas after Administration of Fructooligosaccharide and Lactulose at Different Doses","authors":"M. Kawaguchi, Y. Tashiro, T. Adachi, Z. Tamura","doi":"10.12938/BIFIDUS1982.12.2_57","DOIUrl":"https://doi.org/10.12938/BIFIDUS1982.12.2_57","url":null,"abstract":"Our subject T, who appeared to be a suitable candidate for an assessment of the effects of oligosaccharides, was administrated fructooligosaccharide (FOS) or lactulose and his symptoms, fecal microflora, and composition of rectal gas were investigated. The subject experienced no symptoms in the gut at low dose of FOS. At high dose of FOS, tympanites was observed in the ascending and the transverse colon. By lactulose administration, there were no tympanites, but frequent defecation, rectal gas and loose stool were noted. The number and occupation percentage of fecal bifidobacteria increased by higher doses of FOS (109.1 to 1010.8, 2.9 to 66.2%) and lactulose (108.7 to 1010.5, 0.5 to 25.2%). The composition of rectal gas varied even among samples collected in succession and no clear relationship was observed between the composition of gas and dose. Based on these results, the course of tympanites is discussed.","PeriodicalId":414713,"journal":{"name":"Bifidobacteria and Microflora","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121177725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 22
期刊
Bifidobacteria and Microflora
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1